company background image
688338 logo

Beijing Succeeder Technology SHSE:688338 Stock Report

Last Price

CN¥24.18

Market Cap

CN¥2.6b

7D

-9.4%

1Y

-37.0%

Updated

27 Mar, 2024

Data

Company Financials +

Beijing Succeeder Technology Inc.

SHSE:688338 Stock Report

Market Cap: CN¥2.6b

688338 Stock Overview

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally.

688338 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance3/6
Financial Health5/6
Dividends2/6

Beijing Succeeder Technology Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Beijing Succeeder Technology
Historical stock prices
Current Share PriceCN¥24.18
52 Week HighCN¥45.38
52 Week LowCN¥18.49
Beta0.47
1 Month Change-6.06%
3 Month Change-27.30%
1 Year Change-36.96%
3 Year Change-32.36%
5 Year Changen/a
Change since IPO-81.53%

Recent News & Updates

Recent updates

Shareholder Returns

688338CN Medical EquipmentCN Market
7D-9.4%-5.9%-4.9%
1Y-37.0%-18.0%-16.6%

Return vs Industry: 688338 underperformed the CN Medical Equipment industry which returned -17.1% over the past year.

Return vs Market: 688338 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 688338's price volatile compared to industry and market?
688338 volatility
688338 Average Weekly Movement7.7%
Medical Equipment Industry Average Movement7.7%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688338's share price has been volatile over the past 3 months.

Volatility Over Time: 688338's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003273Hai Wanghttps://www.succeeder.com.cn

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers automatic detection instruments, including coagulation, hemorheology, hematocrit, and platelet aggregation, as well as supporting reagents and consumables. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding diseases.

Beijing Succeeder Technology Inc. Fundamentals Summary

How do Beijing Succeeder Technology's earnings and revenue compare to its market cap?
688338 fundamental statistics
Market capCN¥2.57b
Earnings (TTM)CN¥116.04m
Revenue (TTM)CN¥276.21m

22.1x

P/E Ratio

9.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688338 income statement (TTM)
RevenueCN¥276.21m
Cost of RevenueCN¥0
Gross ProfitCN¥276.21m
Other ExpensesCN¥160.17m
EarningsCN¥116.04m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)1.09
Gross Margin100.00%
Net Profit Margin42.01%
Debt/Equity Ratio0.01%

How did 688338 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

19%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.